ALX Oncology

0 followers

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Headquarters

Employees

Links

Org chart

Jaume Pons

President & Chief Scientific Officer

Jaume Pons

Collapse

Peter García

Chief Financial Officer

Sophia Randolph

Chief Medical Officer

Jeanne Jew

Chief Business Officer

Chris Byrd

General Counsel

Athanasios Tsiatis

SVP, Clinical Development

Yeong-Liang Lin

SVP, Drug Safety & Pharmacovigilance

Michael Chang

VP, Operations

Hank Stern

VP, Chemistry, Manufacturing & Controls

Susan Vermeir

VP, Regulatory Affairs & Quality

Hadi Falahatpisheh

VP, Preclinical Development

Marija Vrljic

VP, Antibody Technologies

Sue Naim

VP, Clinical Operations

Teams

Clinical Development and Operations

11 members

Leadership Team

9 members

Regulatory Affairs and Compliance

7 members

Similar companies

Vaxcyte

2 followers

Kyverna Therapeutics

5 followers

Vizgen

1 follower

Chroma Medicine

1 follower

EvolveImmune Therapeutics

1 follower

Applied Therapeutics

1 follower

Metagenomi

2 followers

Thermo Fisher Scientific

143 followers

Genentech

144 followers

Gilead Sciences

121 followers

Biogen

108 followers

Discover companies